MORE►
Caris Life Sciences
Caris Life Sciences has begun the commercial launch of a blood test designed to detect early signals for multiple types of cancer. [Photo: Caris Life Sciences]
Caris Life Sciences Begins Commercial Launch of Multi-Cancer Early Detection Blood Test
by Lauren Lawley Head | Jul 6, 2026
“We are giving physicians and patients a powerful new tool to help identify cancer earlier and support more informed clinical decisions,” CEO David Dean Halbert says of Caris Detect.
by Sandra Engelland |
Dec 17, 2025
Under the terms of the agreement, Caris is eligible to receive upfront and near-term payments of $25 million and is also eligible for up to $1.1 billion of potential research, development, commercial, and net sales payments, as well as potential tiered royalties on net sales of collaboration therapies, the company said.
MORE►
by Quincy Preston |
Sep 12, 2025
Dallas-Fort Worth-Arlington joins 30 metro areas driving two-thirds of the country's AI job market.
MORE►
by Quincy Preston and David Seeley |
Jun 18, 2025
The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.
MORE►
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]
Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform
by Lance Murray | May 28, 2025
With $1.86 billion raised since 2018 and recent product launches, the North Texas life science company founded in 2008 is preparing for a public debut on the Nasdaq Global Select Market, following a $168 million growth capital round in April.
MORE►
by Lance Murray |
May 8, 2025
Eric Matthews will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris' expanding portfolio of biopharma partnerships, the company said.
MORE►
by Glenn Hunter |
Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE►
by Lance Murray |
Apr 8, 2025
With the new funding, Caris said it has raised $1.86 billion in capital since 2018. Caris will use the raise to bring its science and technologies "to as many patients as possible and further our goal of revolutionizing precision medicine," Founder and CEO David Halbert said.
MORE►
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Photo: Caris]
North Texas’ Caris Life Sciences Gets FDA Approval for its ‘MI Cancer Seek’ Companion Diagnostic Test
by Lance Murray | Nov 6, 2024
Caris said MI Cancer Seek will be used as a companion diagnostic to identify cancer patients who may benefit from treatment with targeted therapies.
MORE►
by Lance Murray |
Oct 24, 2023
Irving-based Caris said that via this multiyear agreement, Moderna will leverage Caris’ extensive library of de-identified, multimodal data solutions derived from whole exome sequencing, whole transcriptome sequencing, and protein analyses—along with claims data to improve development strategies for Moderna’s oncology pipeline.
MORE►
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
D CEO and Dallas Innovates have announced the 2023 Innovation Awards Finalists
Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO
by Lance Murray | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
by Lance Murray |
Oct 21, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Advent International, Stellar, Stream Realty Partners, The Citizenry, Sabre Corp., SB Architects, and others.
MORE►
by Lance Murray |
Sep 16, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Jacobs, HF Sinclair and Holly Energy Partners, Caris Life Sciences, Fossil Group, Deloitte, TRG, Invited, Instil Bio, RealPage, Critical Start, Genuine Article, and others.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
